Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) - Total Liabilities
Based on the latest financial reports, Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) has total liabilities worth CN¥2.94 Billion CNY (≈ $429.75 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 688131 operating cash flow to assess how effectively this company generates cash.
Shanghai Haoyuan Chemexpress Co. Ltd. A - Total Liabilities Trend (2013–2024)
This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Check Shanghai Haoyuan Chemexpress Co. Ltd. A liquidity resilience to evaluate the company's liquid asset resilience ratio.
Shanghai Haoyuan Chemexpress Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Shanghai Haoyuan Chemexpress Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RH
NYSE:RH
|
USA | $4.79 Billion |
|
Jiaozuo Wanfang Aluminum
SHE:000612
|
China | CN¥1.14 Billion |
|
Dermapharm Holding SE
XETRA:DMP
|
Germany | €1.49 Billion |
|
XiAn Shaangu Power Co Ltd
SHG:601369
|
China | CN¥15.20 Billion |
|
Verra Mobility Corp
NASDAQ:VRRM
|
USA | $1.38 Billion |
|
Levi Strauss & Co Class A
NYSE:LEVI
|
USA | $4.57 Billion |
|
Teekay Tankers Ltd
NYSE:TNK
|
USA | $181.93 Million |
|
Foryou Corp
SHE:002906
|
China | CN¥6.39 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Shanghai Haoyuan Chemexpress Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.94 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Haoyuan Chemexpress Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Haoyuan Chemexpress Co. Ltd. A (2013–2024)
The table below shows the annual total liabilities of Shanghai Haoyuan Chemexpress Co. Ltd. A from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.60 Billion ≈ $380.56 Million |
+56.11% |
| 2023-12-31 | CN¥1.67 Billion ≈ $243.78 Million |
+31.61% |
| 2022-12-31 | CN¥1.27 Billion ≈ $185.22 Million |
+130.93% |
| 2021-12-31 | CN¥548.11 Million ≈ $80.21 Million |
+66.58% |
| 2020-12-31 | CN¥329.03 Million ≈ $48.15 Million |
+130.49% |
| 2019-12-31 | CN¥142.75 Million ≈ $20.89 Million |
+12.56% |
| 2018-12-31 | CN¥126.82 Million ≈ $18.56 Million |
+64.83% |
| 2017-12-31 | CN¥76.94 Million ≈ $11.26 Million |
-22.54% |
| 2016-12-31 | CN¥99.34 Million ≈ $14.54 Million |
+137.62% |
| 2015-12-31 | CN¥41.80 Million ≈ $6.12 Million |
+72.14% |
| 2014-12-31 | CN¥24.28 Million ≈ $3.55 Million |
-2.06% |
| 2013-12-31 | CN¥24.80 Million ≈ $3.63 Million |
-- |
About Shanghai Haoyuan Chemexpress Co. Ltd. A
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.